Argus upgraded Gilead Sciences (NASDAQ: GILD) from Hold to Buy with a price target of $100.00.The analyst says the valuation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE